Ir al contenido
· Rellenos dérmicos
SKU 10971

Olidia 365

En stock
Volumen
1 x 365 mg
Laboratorio
PRP Life Science Co., Ltd.
Origen
Corea del Sur
Indicación
Severe facial wrinkles and folds, volume defects, facial lipoatrophy, facial contour deformities
Zonas de tratamiento
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.

Olidia 365 is an injectable PLLA-based dermal filler by PRP Life Science Co., Ltd. in South Korea, designed for deep dermal use. It is suitable for practitioners correcting severe facial wrinkles and folds, replacing volume defects, treating facial lipoatrophy and improving facial contour deformities, with injection into the lower dermis or hypodermis. Each single sterile vial holds 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose and 125 mg mannitol, reconstituted with 5 mL of sterile water for injection before use.

Principales ventajas de Olidia 365

  • Improves severe facial wrinkles and folds
  • Replaces volume defects
  • Improves facial lipoatrophy
  • Improves facial contour deformities
  • PLLA-based formulation designed for a gradual tissue response after injection
Información clave
Marca OLIDIA
Fabricante PRP Life Science Co., Ltd.
País de origen South Korea
Certificación CE-marked (CE 1434)
Composición Per vial (365 mg dry powder): 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, 125 mg mannitol
Envase 1 vial per box (365 mg dry powder), reconstituted with 5 mL of sterile water for injection prior to use
Tipo de uso Professional / clinic use only - injectable PLLA collagen biostimulator for deep dermal/subcutaneous use
Profundidad de inyección Subcutaneous layer / deep dermis
Protocolo / Duración Generated collagen lasts for 2 years, after which the Olidia (PLLA) particles are biodegraded

Indicaciones y uso profesional

Indicaciones principales

  • Severe facial wrinkles and folds
  • Volume defects
  • Facial lipoatrophy
  • Facial contour deformities

Uso profesional

Olidia 365 is intended strictly for professional use by qualified aesthetic practitioners, injected into the deep dermis / subcutaneous layer. For reconstitution, connect an 18G needle to the syringe and add 5 mL of sterile water for injection. For the injection itself, use a 26G sterile cannula or a 26G sterile needle, depending on the case-by-case treatment purpose.

Zonas de tratamiento

  • Face, including moderate to severe nasolabial folds.

Perfil del paciente

Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Do not use in patients with malfunction of the liver or blood coagulation. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.

Cómo funciona Olidia 365 ​

Olidia 365 works through poly-L-lactic acid (PLLA) microparticles that stimulate a gradual tissue response after injection into the subcutaneous layer. This supports correction of severe facial wrinkles and folds, replacement of volume defects, improvement of facial lipoatrophy, and correction of facial contour deformities over time.

Por qué comprar en Allpara

Allpara ofrece productos OLIDIA originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

Is Olidia 365MG suitable for facial lipoatrophy?

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.

What is in the Olidia PLLA 365MG formula?

Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.

How long do the results of Olidia 365 last?

Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
OLIDIA
Laboratorio
PRP Life Science Co., Ltd.
SKU
10971
Formato
1 x 365 mg
Origen
Corea del Sur
Indicación
Severe facial wrinkles and folds, volume defects, facial lipoatrophy, facial contour deformities
Uso
Professional injectable poly-L-lactic acid (PLLA) biostimulator, 365 mg per vial, subcutaneous layer / deep dermal
Zonas de tratamiento
/ Detalles del producto

El expediente completo

Olidia 365 is an injectable PLLA-based dermal filler by PRP Life Science Co., Ltd. in South Korea, designed for deep dermal use. It is suitable for practitioners correcting severe facial wrinkles and folds, replacing volume defects, treating facial lipoatrophy and improving facial contour deformities, with injection into the lower dermis or hypodermis. Each single sterile vial holds 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose and 125 mg mannitol, reconstituted with 5 mL of sterile water for injection before use.

PRP Life Science Co., Ltd., país de origen Corea del Sur.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

Is Olidia 365MG suitable for facial lipoatrophy?

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.

What is in the Olidia PLLA 365MG formula?

Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.

How long do the results of Olidia 365 last?

Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

Is Olidia 365MG suitable for facial lipoatrophy?
Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.
What is in the Olidia PLLA 365MG formula?
Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.
How long do the results of Olidia 365 last?
Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.
/ FAQ

Preguntas frecuentes

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.
Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.
Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

Más productos de PRP Life Science

Ver laboratorio

Alternativas para la clínica

Todos los productos

Olidia 365

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Olidia 365 is an injectable PLLA-based dermal filler by PRP Life Science Co., Ltd. in South Korea, designed for deep dermal use. It is suitable for practitioners correcting severe facial wrinkles and folds, replacing volume defects, treating facial lipoatrophy and improving facial contour deformities, with injection into the lower dermis or hypodermis. Each single sterile vial holds 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose and 125 mg mannitol, reconstituted with 5 mL of sterile water for injection before use.

Principales ventajas de Olidia 365

  • Improves severe facial wrinkles and folds
  • Replaces volume defects
  • Improves facial lipoatrophy
  • Improves facial contour deformities
  • PLLA-based formulation designed for a gradual tissue response after injection
Información clave
Marca OLIDIA
Fabricante PRP Life Science Co., Ltd.
País de origen South Korea
Certificación CE-marked (CE 1434)
Composición Per vial (365 mg dry powder): 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, 125 mg mannitol
Envase 1 vial per box (365 mg dry powder), reconstituted with 5 mL of sterile water for injection prior to use
Tipo de uso Professional / clinic use only - injectable PLLA collagen biostimulator for deep dermal/subcutaneous use
Profundidad de inyección Subcutaneous layer / deep dermis
Protocolo / Duración Generated collagen lasts for 2 years, after which the Olidia (PLLA) particles are biodegraded

Indicaciones y uso profesional

Indicaciones principales

  • Severe facial wrinkles and folds
  • Volume defects
  • Facial lipoatrophy
  • Facial contour deformities

Uso profesional

Olidia 365 is intended strictly for professional use by qualified aesthetic practitioners, injected into the deep dermis / subcutaneous layer. For reconstitution, connect an 18G needle to the syringe and add 5 mL of sterile water for injection. For the injection itself, use a 26G sterile cannula or a 26G sterile needle, depending on the case-by-case treatment purpose.

Zonas de tratamiento

  • Face, including moderate to severe nasolabial folds.

Perfil del paciente

Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Do not use in patients with malfunction of the liver or blood coagulation. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.

Cómo funciona Olidia 365 ​

Olidia 365 works through poly-L-lactic acid (PLLA) microparticles that stimulate a gradual tissue response after injection into the subcutaneous layer. This supports correction of severe facial wrinkles and folds, replacement of volume defects, improvement of facial lipoatrophy, and correction of facial contour deformities over time.

Por qué comprar en Allpara

Allpara ofrece productos OLIDIA originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

Is Olidia 365MG suitable for facial lipoatrophy?

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.

What is in the Olidia PLLA 365MG formula?

Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.

How long do the results of Olidia 365 last?

Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

Más productos de PRP Life Science

Ver el laboratorio →

Olidia 365 is an injectable PLLA-based dermal filler by PRP Life Science Co., Ltd. in South Korea, designed for deep dermal use. It is suitable for practitioners correcting severe facial wrinkles and folds, replacing volume defects, treating facial lipoatrophy and improving facial contour deformities, with injection into the lower dermis or hypodermis. Each single sterile vial holds 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose and 125 mg mannitol, reconstituted with 5 mL of sterile water for injection before use.

PRP Life Science Co., Ltd., país de origen Corea del Sur.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

Is Olidia 365MG suitable for facial lipoatrophy?

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.

What is in the Olidia PLLA 365MG formula?

Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.

How long do the results of Olidia 365 last?

Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.